最新报道:Rollman Management has invested $5 million in PharmaTech AI to enhance AI-driven drug research. The funding will support the development of advanced machine learning models for pharmaceutical innovation, aiming to accelerate drug discovery and reduce costs. PharmaTech AI specializes in leveraging AI to analyze complex biological data, improving efficiency in identifying potential treatments. Rollman Management's investment underscores growing confidence in AI's role in transforming healthcare and biotech industries.